-
2
-
-
0011923651
-
-
OSAP Prevention Monograph-1, DHHS Publication No. ADM 89-1645. Rockville, MD: U.S. Department of Health and Human Services, Office for Substance Abuse Prevention
-
DuPont, R. L. (Ed.). (1989). Stopping alcohol and other drug use before it starts: The future of prevention (OSAP Prevention Monograph-1, DHHS Publication No. ADM 89-1645). Rockville, MD: U.S. Department of Health and Human Services, Office for Substance Abuse Prevention.
-
(1989)
Stopping Alcohol and Other Drug Use before It Starts: The Future of Prevention
-
-
DuPont, R.L.1
-
3
-
-
0012600844
-
Facing and preventing teenage alcohol and other drug use
-
Lesson 3, New York: Hatherleigh
-
DuPont, R. L. (1994). Facing and preventing teenage alcohol and other drug use. Directions in Substance Abuse Counseling, 2, Lesson 3, 1-13. New York: Hatherleigh.
-
(1994)
Directions in Substance Abuse Counseling
, vol.2
, pp. 1-13
-
-
DuPont, R.L.1
-
4
-
-
0029056838
-
Anxiety and addiction: A clinical perspective on comorbidity
-
DuPont, R. L. (1995). Anxiety and addiction: A clinical perspective on comorbidity. Bulletin of the Menninger Clinic, 59(Suppl. A), A53-A72.
-
(1995)
Bulletin of the Menninger Clinic
, vol.59
, Issue.SUPPL. A
-
-
DuPont, R.L.1
-
5
-
-
0030463949
-
Harm reduction and decriminalization in the United States: A personal perspective
-
DuPont, R. L. (1996). Harm reduction and decriminalization in the United States: A personal perspective. Substance Use & Misuse, 31, 1929-1945.
-
(1996)
Substance Use & Misuse
, vol.31
, pp. 1929-1945
-
-
DuPont, R.L.1
-
6
-
-
0030992782
-
Panic disorder and addiction: The clinical issues of comorbidity
-
DuPont, R. L. (1997a). Panic disorder and addiction: The clinical issues of comorbidity. Bulletin of the Menninger Clinic, 61(Suppl. A), A54-A65.
-
(1997)
Bulletin of the Menninger Clinic
, vol.61
, Issue.SUPPL. A
-
-
DuPont, R.L.1
-
7
-
-
2642617909
-
Psychotherapy in addictive disorders
-
N. S. Miller (Ed.), Philadelphia: W.B. Saunders Co.
-
DuPont, R. L. (1997b). Psychotherapy in addictive disorders. In N. S. Miller (Ed.), Addictions in psychiatry (pp. 370-377). Philadelphia: W.B. Saunders Co.
-
(1997)
Addictions in Psychiatry
, pp. 370-377
-
-
DuPont, R.L.1
-
9
-
-
2642708488
-
Implications for prevention policy
-
in press. W. J. Bukoski (Ed.), National Institute on Drug Abuse Research Monograph, NIH Publication No. 97-4021. Rockville, MD: U.S. Department of Health and Human Services, National Institute on Drug Abuse
-
DuPont, R. L. (in press). Implications for prevention policy. In W. J. Bukoski (Ed.), Cost-benefit/cost effectiveness research of drug abuse prevention: Implications for programming and policy (National Institute on Drug Abuse Research Monograph, NIH Publication No. 97-4021). Rockville, MD: U.S. Department of Health and Human Services, National Institute on Drug Abuse.
-
Cost-benefit/cost Effectiveness Research of Drug Abuse Prevention: Implications for Programming and Policy
-
-
DuPont, R.L.1
-
10
-
-
0004940473
-
Sedatives/hypnotics and benzodiazepines
-
in press. R. J. Frances & S. I. Miller (Eds.), New York: Guilford
-
DuPont, R. L., & DuPont, C. M. (in press). Sedatives/hypnotics and benzodiazepines. In R. J. Frances & S. I. Miller (Eds.), Clinical textbook of addictive disorders (2nd ed.). New York: Guilford.
-
Clinical Textbook of Addictive Disorders (2nd Ed.)
-
-
DuPont, R.L.1
DuPont, C.M.2
-
11
-
-
21844518038
-
Withdrawal and reward: Implications for detoxification and relapse prevention
-
DuPont, R. L., & Gold, M. S. (1995). Withdrawal and reward: Implications for detoxification and relapse prevention. Psychiatric Annals, 25, 663-668.
-
(1995)
Psychiatric Annals
, vol.25
, pp. 663-668
-
-
DuPont, R.L.1
Gold, M.S.2
-
14
-
-
0029088984
-
Drug legalization, harm reduction, and drug policy
-
DuPont, R. L., & Voth, E. A. (1995). Drug legalization, harm reduction, and drug policy. Annals of Internal Medicine, 123, 461-465.
-
(1995)
Annals of Internal Medicine
, vol.123
, pp. 461-465
-
-
DuPont, R.L.1
Voth, E.A.2
|